(REG) Regency Centers - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US7588491032
Stock: Shopping centers, Grocers, Retailers, Restaurants, Services
Total Rating 49
Risk 50
Buy Signal 1.37
| Risk 5d forecast | |
|---|---|
| Volatility | 17.3% |
| Relative Tail Risk | -1.63% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.39 |
| Alpha | 3.91 |
| Character TTM | |
|---|---|
| Beta | 0.136 |
| Beta Downside | 0.244 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.10% |
| CAGR/Max DD | 0.89 |
EPS (Earnings per Share)
Revenue
Description: REG Regency Centers March 05, 2026
Regency Centers Corporation (REG) is a Real Estate Investment Trust (REIT) specializing in the ownership, operation, and development of grocery-anchored shopping centers in affluent suburban markets across the United States. Retail REITs typically focus on generating income through property leases.
The companys portfolio is characterized by properties featuring a mix of essential service providers, including grocery stores and restaurants, alongside other retailers. This business model often provides stable cash flow due to the necessity of grocery services, which typically perform well across economic cycles.
REG operates as a fully integrated real estate company and is a member of the S&P 500 Index. For further in-depth analysis of REGs financial performance and market position, consider exploring its profile on ValueRay.
Headlines to watch out for
- Suburban grocery-anchored retail demand drives rental income
- Interest rate fluctuations impact financing costs and property values
- Consumer spending trends directly affect tenant sales and occupancy
- New property developments expand portfolio and future revenue streams
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 629.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.64 > 1.0 |
| NWC/Revenue: 1.01% < 20% (prev -8.22%; Δ 9.24% < -1%) |
| CFO/TA 0.06 > 3% & CFO 827.7m > Net Income 629.7m |
| Net Debt (5.82b) to EBITDA (1.07b): 5.41 < 3 |
| Current Ratio: 1.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (183.1m) vs 12m ago 0.72% < -2% |
| Gross Margin: 60.52% > 18% (prev 0.71%; Δ 5.98k % > 0.5%) |
| Asset Turnover: 13.26% > 50% (prev 12.13%; Δ 1.13% > 0%) |
| Interest Coverage Ratio: 3.32 > 6 (EBITDA TTM 1.07b / Interest Expense TTM 204.9m) |
Altman Z'' -0.49
| A: 0.00 (Total Current Assets 394.5m - Total Current Liabilities 377.5m) / Total Assets 13.00b |
| B: -0.15 (Retained Earnings -1.99b / Total Assets 13.00b) |
| C: 0.05 (EBIT TTM 680.7m / Avg Total Assets 12.70b) |
| D: -0.34 (Book Value of Equity -1.99b / Total Liabilities 5.82b) |
| Altman-Z'' Score: -0.49 = B |
Beneish M -2.88
| DSRI: 0.90 (Receivables 273.9m/271.8m, Revenue 1.68b/1.50b) |
| GMI: 1.18 (GM 60.52% / 71.19%) |
| AQI: 1.00 (AQ_t 0.94 / AQ_t-1 0.95) |
| SGI: 1.12 (Revenue 1.68b / 1.50b) |
| TATA: -0.02 (NI 629.7m - CFO 827.7m) / TA 13.00b) |
| Beneish M-Score: -2.88 (Cap -4..+1) = A |
What is the price of REG shares?
As of March 12, 2026, the stock is trading at USD 78.16 with a total of 913,870 shares traded.
Over the past week, the price has changed by -1.48%, over one month by +2.55%, over three months by +17.04% and over the past year by +10.78%.
Over the past week, the price has changed by -1.48%, over one month by +2.55%, over three months by +17.04% and over the past year by +10.78%.
Is REG a buy, sell or hold?
Regency Centers has received a consensus analysts rating of 4.25.
Therefore, it is recommended to buy REG.
- StrongBuy: 10
- Buy: 5
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the REG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 81.5 | 4.2% |
| Analysts Target Price | 81.5 | 4.2% |
REG Fundamental Data Overview March 10, 2026
P/E Trailing = 27.7411
P/E Forward = 33.3333
P/S = 9.0681
P/B = 2.1532
P/EG = 2.6072
Revenue TTM = 1.68b USD
EBIT TTM = 680.7m USD
EBITDA TTM = 1.07b USD
Long Term Debt = 4.62b USD (from longTermDebt, last quarter)
Short Term Debt = 377.5m USD (from shortTermDebt, last quarter)
Debt = 5.94b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.82b USD (from netDebt column, last quarter)
Enterprise Value = 20.43b USD (14.61b + Debt 5.94b - CCE 120.7m)
Interest Coverage Ratio = 3.32 (Ebit TTM 680.7m / Interest Expense TTM 204.9m)
EV/FCF = 29.18x (Enterprise Value 20.43b / FCF TTM 700.0m)
FCF Yield = 3.43% (FCF TTM 700.0m / Enterprise Value 20.43b)
FCF Margin = 41.57% (FCF TTM 700.0m / Revenue TTM 1.68b)
Net Margin = 37.40% (Net Income TTM 629.7m / Revenue TTM 1.68b)
Gross Margin = 60.52% ((Revenue TTM 1.68b - Cost of Revenue TTM 664.8m) / Revenue TTM)
Gross Margin QoQ = 55.22% (prev 44.49%)
Tobins Q-Ratio = 1.57 (Enterprise Value 20.43b / Total Assets 13.00b)
Interest Expense / Debt = 0.89% (Interest Expense 52.6m / Debt 5.94b)
Taxrate = 21.0% (US default 21%)
NOPAT = 537.7m (EBIT 680.7m * (1 - 21.00%))
Current Ratio = 1.05 (Total Current Assets 394.5m / Total Current Liabilities 377.5m)
Debt / Equity = 0.86 (Debt 5.94b / totalStockholderEquity, last quarter 6.91b)
Debt / EBITDA = 5.41 (Net Debt 5.82b / EBITDA 1.07b)
Debt / FCF = 8.31 (Net Debt 5.82b / FCF TTM 700.0m)
Total Stockholder Equity = 6.77b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.96% (Net Income 629.7m / Total Assets 13.00b)
RoE = 9.30% (Net Income TTM 629.7m / Total Stockholder Equity 6.77b)
RoCE = 5.98% (EBIT 680.7m / Capital Employed (Equity 6.77b + L.T.Debt 4.62b))
RoIC = 4.75% (NOPAT 537.7m / Invested Capital 11.32b)
WACC = 4.77% (E(14.61b)/V(20.55b) * Re(6.42%) + D(5.94b)/V(20.55b) * Rd(0.89%) * (1-Tc(0.21)))
Discount Rate = 6.42% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.50%
[DCF] Terminal Value 86.55% ; FCFF base≈718.6m ; Y1≈734.2m ; Y5≈811.5m
[DCF] Fair Price = 100.2 (EV 24.15b - Net Debt 5.82b = Equity 18.33b / Shares 182.9m; r=5.90% [WACC]; 5y FCF grow 2.03% → 2.90% )
EPS Correlation: -1.69 | EPS CAGR: -0.96% | SUE: 4.0 | # QB: 1
Revenue Correlation: 89.82 | Revenue CAGR: 13.40% | SUE: 1.43 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.59 | Chg7d=-0.013 | Chg30d=-0.007 | Revisions Net=+1 | Analysts=5
EPS current Year (2026-12-31): EPS=2.41 | Chg7d=-0.006 | Chg30d=-0.009 | Revisions Net=-3 | Growth EPS=-14.6% | Growth Revenue=+5.2%
EPS next Year (2027-12-31): EPS=2.53 | Chg7d=-0.028 | Chg30d=-0.044 | Revisions Net=-3 | Growth EPS=+5.1% | Growth Revenue=+3.0%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.3% (Discount Rate 7.9% - Earnings Yield 3.6%)
[Growth] Growth Spread = +3.6% (Analyst 7.9% - Implied 4.3%)
P/E Forward = 33.3333
P/S = 9.0681
P/B = 2.1532
P/EG = 2.6072
Revenue TTM = 1.68b USD
EBIT TTM = 680.7m USD
EBITDA TTM = 1.07b USD
Long Term Debt = 4.62b USD (from longTermDebt, last quarter)
Short Term Debt = 377.5m USD (from shortTermDebt, last quarter)
Debt = 5.94b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.82b USD (from netDebt column, last quarter)
Enterprise Value = 20.43b USD (14.61b + Debt 5.94b - CCE 120.7m)
Interest Coverage Ratio = 3.32 (Ebit TTM 680.7m / Interest Expense TTM 204.9m)
EV/FCF = 29.18x (Enterprise Value 20.43b / FCF TTM 700.0m)
FCF Yield = 3.43% (FCF TTM 700.0m / Enterprise Value 20.43b)
FCF Margin = 41.57% (FCF TTM 700.0m / Revenue TTM 1.68b)
Net Margin = 37.40% (Net Income TTM 629.7m / Revenue TTM 1.68b)
Gross Margin = 60.52% ((Revenue TTM 1.68b - Cost of Revenue TTM 664.8m) / Revenue TTM)
Gross Margin QoQ = 55.22% (prev 44.49%)
Tobins Q-Ratio = 1.57 (Enterprise Value 20.43b / Total Assets 13.00b)
Interest Expense / Debt = 0.89% (Interest Expense 52.6m / Debt 5.94b)
Taxrate = 21.0% (US default 21%)
NOPAT = 537.7m (EBIT 680.7m * (1 - 21.00%))
Current Ratio = 1.05 (Total Current Assets 394.5m / Total Current Liabilities 377.5m)
Debt / Equity = 0.86 (Debt 5.94b / totalStockholderEquity, last quarter 6.91b)
Debt / EBITDA = 5.41 (Net Debt 5.82b / EBITDA 1.07b)
Debt / FCF = 8.31 (Net Debt 5.82b / FCF TTM 700.0m)
Total Stockholder Equity = 6.77b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.96% (Net Income 629.7m / Total Assets 13.00b)
RoE = 9.30% (Net Income TTM 629.7m / Total Stockholder Equity 6.77b)
RoCE = 5.98% (EBIT 680.7m / Capital Employed (Equity 6.77b + L.T.Debt 4.62b))
RoIC = 4.75% (NOPAT 537.7m / Invested Capital 11.32b)
WACC = 4.77% (E(14.61b)/V(20.55b) * Re(6.42%) + D(5.94b)/V(20.55b) * Rd(0.89%) * (1-Tc(0.21)))
Discount Rate = 6.42% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.50%
[DCF] Terminal Value 86.55% ; FCFF base≈718.6m ; Y1≈734.2m ; Y5≈811.5m
[DCF] Fair Price = 100.2 (EV 24.15b - Net Debt 5.82b = Equity 18.33b / Shares 182.9m; r=5.90% [WACC]; 5y FCF grow 2.03% → 2.90% )
EPS Correlation: -1.69 | EPS CAGR: -0.96% | SUE: 4.0 | # QB: 1
Revenue Correlation: 89.82 | Revenue CAGR: 13.40% | SUE: 1.43 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.59 | Chg7d=-0.013 | Chg30d=-0.007 | Revisions Net=+1 | Analysts=5
EPS current Year (2026-12-31): EPS=2.41 | Chg7d=-0.006 | Chg30d=-0.009 | Revisions Net=-3 | Growth EPS=-14.6% | Growth Revenue=+5.2%
EPS next Year (2027-12-31): EPS=2.53 | Chg7d=-0.028 | Chg30d=-0.044 | Revisions Net=-3 | Growth EPS=+5.1% | Growth Revenue=+3.0%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.3% (Discount Rate 7.9% - Earnings Yield 3.6%)
[Growth] Growth Spread = +3.6% (Analyst 7.9% - Implied 4.3%)